Zhengduozhe Technology, Inc (OTCPK: ZDZT)
Health Care · Biotechnology · CN
$—
— today · — 1Y
Zhengduozhe Technology, Inc (OTCPK: ZDZT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $881.55K.
trading between 0.55 and 1.92.
ZDZT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $881.55K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 13.60
- 52-week high
- $1.92
- 52-week low
- $0.55
- Avg volume (3M)
- —
- Shares outstanding
- 1.55M
- Employees
- —
- Next earnings
- —
About Zhengduozhe Technology, Inc
Zhengduozhe Technology Inc., operating as DAKOTA Life Sciences, is a biopharmaceutical enterprise dedicated to the acquisition, development, and commercialization of therapeutic agents. These pharmaceuticals are specifically engineered to prevent and treat severe medical conditions encountered in both clinical and community environments. A central focus for the company involves delivering solutions to individuals grappling with antimicrobial resistance and ensuring that necessary medications are available at reasonable prices. The firm was established in 1986 and is headquartered in Sioux Falls, South Dakota.
- ISIN
- US48583U2069
- Founded
- 1986
- Listed since
- Feb 1, 1995
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €864.20 | -4.19% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $138.89 | -4.26% |
Figures last refreshed Aug 18, 2026.